Animal work is not a result in people
Most reports of faster tendon repair with BPC-157 are from rat studies. A tendon joins muscle to bone. These findings do not show that it helps people (evidence checked September 28, 2026).
Ask whether a claim rests on animals, a report from people or a trial with a group for comparison. These answer different questions.
The human record is small
The human research covered five studies. Together they gave BPC-157 to about 80 people. Those are the counts in the review by the FDA, which oversees US medicines (checked September 28, 2026).
Only two studies included a group for comparison. Neither had been published as a full paper in that FDA review.
A comparison group gets a different treatment or a dummy treatment with no active medicine. Researchers can then compare what happened in the groups.
Feeling better does not establish the cause
Small reports describe people feeling better after BPC-157. With no group for comparison, they cannot show that BPC-157 caused the change (reports reviewed September 28, 2026).
The missing comparison matters when a report is offered as proof. Ask what else might explain the change.
A planned trial is not a finding
In China, a study of BPC-157 had started for hamstring strains. A hamstring strain is an injury to the muscles behind your thigh. Its public study record had no results posted when checked September 28, 2026.
No completed injury trial with a dummy-treatment group had reported a result at that check.
A study entry describes a plan and its status. Look for actual results before treating it as evidence of benefit.
What can short reports establish?
The FDA says the studies are too short and small to show that BPC-157 is safe (review checked September 28, 2026).
Find the study records